# Cognitive Behavioral Therapy for Insomnia in Postpartum Depression: A Meta-Analysis of Therapeutic Outcomes and Barriers to Clinical Use

**Authors:** Zeeshan Ali, Osama Akhtar, Zekra Ehsaan, Muhammad Maaz, Shadman Ahmad, Muhammad Daniyal

PMC · DOI: 10.7759/cureus.102902 · 2026-02-03

## TL;DR

This study finds that cognitive behavioral therapy for insomnia (CBT-I) can help reduce insomnia and improve sleep in postpartum women, with some evidence of reducing depression.

## Contribution

The study is the first meta-analysis to evaluate CBT-I's effects on postpartum depression and insomnia severity in perinatal women.

## Key findings

- CBT-I significantly reduces insomnia severity in perinatal women.
- CBT-I shows borderline significant reduction in postpartum depression scores.
- CBT-I improves total sleep time in perinatal women when an outlier study is excluded.

## Abstract

Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment for insomnia in the general population and pregnant women. However, its effects on postpartum depression remain underexplored.

Objectives of this meta-analytic review were to evaluate the effects of CBT-I on postpartum depression, insomnia severity, and total sleep time in perinatal women.

PubMed, ScienceDirect, and Google Scholar databases were searched. Randomized controlled trials with perinatal women, CBT-I as intervention, and comparison with any other intervention were included. Bias was evaluated using the Cochrane Risk of Bias 2 (RoB 2) tool. Four studies were deemed eligible, with a combined sample size of 381 participants. Insomnia severity, postpartum depression, and total sleep time were selected as outcomes. Mean differences were calculated with 95% confidence interval (CI), and heterogeneity was assessed using I2 statistics.

For insomnia severity, a mean difference of -2.30 (95% CI: -4.10 to -0.49, P = 0.0126) was obtained, favoring the CBT-I group. For postpartum depression, a standardized mean difference of -0.20 (95% CI: -0.40 to 0.00; P = 0.0502) showed borderline statistical significance, also favoring the CBT-I group. However, for total sleep time, a mean difference of 0.44 (95% CI: -0.04 to 0.92; P = 0.075) with 66% heterogeneity showed nonsignificant results, mainly due to an outlier study. With this outlier study, the heterogeneity dropped to 0%, the mean difference increased to 0.68 (95% CI: 0.37-0.99), reaching statistical significance (P < 0.0001).

This meta-analysis demonstrates that CBT-I significantly reduces insomnia severity and improves total sleep time in perinatal women, with a borderline significant reduction in postpartum depression scores. Despite its growing evidence, it remains an underutilized treatment option. By incorporating it, the overall quality of maternal healthcare services can be improved.

## Linked entities

- **Diseases:** postpartum depression (MONDO:0005929), insomnia (MONDO:0013600)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** poor (MESH:D009123), Perinatal Depression (MESH:D066087), sleep fragmentation (MESH:D012892), Depression (MESH:D003866), Mental Disorders (MESH:D001523), CBT-I (MESH:D007319), Postpartum Depression (MESH:D019052), anxiety (MESH:D001007), inflammatory (MESH:D007249), Sleep problems (MESH:D012893), major depression (MESH:D003865), fatigue (MESH:D005221), I (MESH:D006969)
- **Chemicals:** serotonin (MESH:D012701), GABA (MESH:D005680), progesterone (MESH:D011374)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962287/full.md

---
Source: https://tomesphere.com/paper/PMC12962287